The $43B Big Pharma Story is Starting Over-With a New Player
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
| Open | 125.83 | Prev Close | 126.32 |
| High | 127.57 | Low | 125.83 |
| Volume | 307,238 | Volume (Avg) | 6,191 |
| 52 Week High | 139.33 | 52 Week Low | 109.21 |
| Market Cap | 219.9B | PE Ratio | 15.86 |
General
| Name | Abbott Laboratories |
| Ticker | ABT |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 114,000 |
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Highlights
| Analyst Target | 145.38 |
| Market Cap | 219,923,800,000 |
| PE Ratio | 15.86 |
| PEG Ratio | 4.17 |
| EBITDA | 11,747,000,320 |
Valuation
| Trailing PE | 15.87 |
| Forward PE | 22.52 |
| Price/Sales (Trailing 12 Mt.) | 5.01 |
| Price/Book (Most Recent Quarter) | 4.37 |
Technicals
| Beta | 0.72 |
| 52 Week High | 139.33 |
| 52 Week Low | 109.21 |
| 50 Day Average | -1.95% |
| 200 Day Average | -3.43% |
Dividend
Abbott Laboratories pays out a dividend of $2.38 per share, with a dividend yield of 1.88%.
ABT's last dividend payment was made to shareholders on November 17, 2025.
They pay out 29.33% of their earnings out as a dividend.
Recent Dividends
| Nov 17, 2025 | $0.59 |
| Aug 15, 2025 | $0.59 |
| May 15, 2025 | $0.59 |
| Feb 14, 2025 | $0.59 |
| Nov 15, 2024 | $0.55 |
| Aug 15, 2024 | $0.55 |
| May 15, 2024 | $0.55 |
| Feb 15, 2024 | $0.55 |
Trump 'Very Seriously' Considering Australian Retirement Savings System For US Working People: 'It's A Good Plan'
President Donald Trump has revealed that his administration is actively exploring the possibility of implementing a retirement savings system similar to Australia's in the United States.
How To Earn $500 A Month From Dollar General Stock Ahead Of Q3 Earnings
Dollar General offers an annual dividend yield of 2.14% ($2.36 a year). How can investors exploit this to pocket a regular $500 monthly?
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Jim Cramer's '10 Stocks To Own For The Future' In 2000 Cost This Redditor A Decade Of Retirement, Says Having To Work 10 More Years Was 'Painful'
A Reddit user slammed Jim Cramer's stock picks at the peak of the Dot-Com bubble, saying that the CNBC host's suggestions cost him a decade of retirement.
Google's Chinese Rival Hits Growth Roadblock Amid Mass Layoffs After Disappointing Q3
Baidu's Growth score plummets to 1.82% amid mass layoffs. See why China's Google hit a roadblock after a brutal Q3 in this ranking analysis.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Mohamed El-Erian Says The Federal Reserve Needs A Reset, Cites Deep Structural Issues — 'This Fed Went To Sleep'
Leading economist Mohamed El-Erian is calling for sweeping reforms at the Federal Reserve, warning that the central bank's credibility is at risk following a prolonged period of policy missteps and internal dysfunction in recent years.
These are the 37 donors helping pay for Trump's $300 million White House ballroom
WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”
First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad
This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.
Joan Branson, wife of British billionaire Richard Branson, dies at 80
Joan Branson, the wife of British billionaire Richard Branson, has died at age 80.
Deadly Asian floods are no fluke. They’re a climate warning, scientists say
HANOI, Vietnam (AP) — Southeast Asia is being pummeled by unusually severe floods this year, as late-arriving storms and relentless rains wreak havoc that has caught many places off guard.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
(Micro)Strategy's Structural Reset: Why Markets Are Repricing MSTR Beyond Bitcoin
The recent decline in Strategy's (NASDAQ:MSTR) stock price is not a simple pullback, nor is it a reaction driven by short-term sentiment. What is unfolding around MSTR is a broad structural repricing.
Samsung Vs Apple: The Foldable Phone War Just Went Nuclear
Samsung just launched a game-changing foldable phone, putting pressure on Apple's rumored foldable iPhone. Will foldables become mainstream?
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Stock Market Today: S&P 500, Nasdaq Futures Rise After Breaking 5-Day Winning Streak—MongoDB, CrowdStrike, American Eagle In Focus
U.S. stock futures rose on Tuesday after declining on Monday. Futures of major benchmark indices were higher. On Monday, the month of December kicked off with benchmark indices declining after a five-day winning streak.
Trump Withdraws Support For 'Wacky' Marjorie Taylor Greene In Sudden, Fiery Split: 'I Can't Take...'
President Donald Trump said he is withdrawing his endorsement of longtime ally Rep. Marjorie Taylor Greene — here's what happened.
The Market Just Crossed a Dangerous Line - Ad
The man who predicted the 2008 crash and 2020 says today's soaring markets are NOT a bubble - they're something far stranger and more dangerous. He says it's about to change everything you know about money.
Elon Musk Says He Doesn't Buy Stocks, But Thinks Google Will Be 'Pretty Valuable' In The Future And Nvidia's An 'Obvious' One
Elon Musk says he doesn't invest in stocks but believes Google and Nvidia are best positioned to dominate the future economy through AI, robotics, and space, while both companies continue to post strong earnings and market gains.
Peter Lynch on AI Stocks: 'I Literally Couldn't Pronounce Nvidia Until About Eight Months Ago'
Peter Lynch has stated that he does not hold any artificial intelligence (AI) stocks, despite the sector's recent surge.
The Next Biggest Bull Run In Over 50 Years - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
AT&T reached a $177M data breach settlement. What consumers should know about claiming their money
NEW YORK (AP) — AT&T has reached a combined $177 million settlement over two . And impacted consumers have a little over a month left to file a claim for their chunk of the money.
Silver Soars To Record Highs: It's Up 95% In 2025, The Best Year Since 1979
Silver prices surge over 5% as investors rush to secure metal amid tight supplies and global shortage concerns, driving up stocks and mining equities.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
Cathie Wood Bets Big On These Stocks As Bitcoin, Ethereum Crash —Dumps Instagram Rival
On Tuesday, Cathie Wood-led Ark Invest made significant trades, notably increasing its holdings in Bullish (NYSE:BLSH), Coinbase Glo
All 14 victims identified from fiery UPS cargo plane crash in Louisville
LOUISVILLE, Ky. (AP) — A grandfather and his young granddaughter. An electrician with two young children. A woman standing in line at a scrap metal business.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Silver Breaks Out In A Short Squeeze, Rising Yields In Japan Hits Stocks and Bitcoin
Rising Yields In Japan
Trump says he's rebuilding Dulles airport while his administration is fixing the 'people movers'
WASHINGTON (AP) — President Donald Trump said Tuesday that his administration will embark on a reconstruction of Dulles International Airport in northern Virginia.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Barrick's Breakup Rumors, North America Versus The World
Barrick Mining (NYSE: B) may split into two companies, one focused on North America and another on Africa and Asia.
Trump's $2,000 Tariff Dividend Stumbles On Math: Cost Far Exceeds Revenue
Trump's $2,000 tariff rebate plan faces a major math gap, with estimated costs up to $606.8B—far exceeding tariff revenues in 2025 and 2026, says the Tax Foundation.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
MSNBC's name is being replaced, but its leaders insist that its mission will remain the same
NEW YORK (AP) — Asked what viewers should expect when television's MSNBC makes its from NBC News final this weekend, network president Rebecca Kutler points to a poster on the wall of a conference room at its new offices off Times Square.
OpenAI CEO Sam Altman declares 'code red' to improve ChatGPT amid rising competition in AI chatbots
SAN FRANCISCO (AP) — OpenAI CEO Sam Altman has set off a “code red” alert to employees to improve its flagship product, ChatGPT, and delay other product developments, according to The Wall Street Journal.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Nokia Secures Multi-Year Pact To Power Telecom Italia's 5G Expansion
Nokia (NYSE: NOK) secures 3-year deal with Telecom Italia (OTC: TIIAY) to expand 5G coverage in Italy using latest equipment.
What to know about the apartment tower fire in Hong Kong
HONG KONG (AP) — Hong Kong firefighters were making a final push to try and find any survivors from the city's , going apartment-to-apartment in the high-rise complex in an exhaustive search.
First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad
This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.
Evommune's Skin Disorder Candidate Has 'Blockbuster Commercial Opportunity': Analyst Projects $5 Billion Peak Sales
Evommune gains an Outperform rating as William Blair cites strong EVO756 trial data and blockbuster sales potential.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.